We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Draft Guidance Seeks to Improve Patient Labeling on LASIK Devices
FDA Draft Guidance Seeks to Improve Patient Labeling on LASIK Devices
In a draft guidance released yesterday, the FDA recommended improvements in patient labeling information on laser-assisted in situ keratomileusis (LASIK) devices so patients can better understand the benefits and risks involved.